98 related articles for article (PubMed ID: 3836746)
21. [Therapeutic effects of a highly attenuted live measles-virus vaccine of simple herpetic keratitis: a preliminary report of 50 cases (author's transl)].
Tang QZ
Zhonghua Yan Ke Za Zhi; 1979; 15(3):156-8. PubMed ID: 122183
[No Abstract] [Full Text] [Related]
22. [A compound catalytic model with both simple and reversible types and its applications in disease surveillance].
Zhang YX
Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Apr; 6(2):115-8. PubMed ID: 4016898
[No Abstract] [Full Text] [Related]
23. [The impact of immunization against measles on epidemiology of measles in Poland].
Janaszek W
Przegl Epidemiol; 1998; 52(4):413-25. PubMed ID: 10321085
[TBL] [Abstract][Full Text] [Related]
24. Mass measles control in West and Central Africa.
Foster SO; Pifer JM
Afr J Med Sci; 1971 Apr; 2(2):151-8. PubMed ID: 5111614
[TBL] [Abstract][Full Text] [Related]
25. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
[No Abstract] [Full Text] [Related]
26. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
Nasibov MN; Yakovleva NV; Smorodintsev AA
Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205
[No Abstract] [Full Text] [Related]
27. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
[No Abstract] [Full Text] [Related]
28. [Epidemiologic and clinical results of measles immunization in the district Karl-Marx-city].
Hajduk F; Hempel HC
Dtsch Gesundheitsw; 1968 Dec; 23(52):2483-9. PubMed ID: 5715950
[No Abstract] [Full Text] [Related]
29. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
[No Abstract] [Full Text] [Related]
30. [Serum titration of children vaccinated against measles].
Morzycka M; Barteczkoi
Pediatr Pol; 1968 Jul; 43(7):813-6. PubMed ID: 4174897
[No Abstract] [Full Text] [Related]
31. Measles emerges.
Goonaratna C
Natl Med J India; 2000; 13(2):98-9. PubMed ID: 10835860
[No Abstract] [Full Text] [Related]
32. [Measles vaccination of pre-school children: a detailed study of reaction frequency and side effects after immunization with vaccine of 3 different strengths].
Böttiger M; Heller L; Kamensky P; Svanberg B
Lakartidningen; 1974 Sep; 71(36):3270-4. PubMed ID: 4410083
[No Abstract] [Full Text] [Related]
33. Development of extremely attenuated live measles virus vaccine (CAM-EX).
Ueda S; Takahashi M; Kurimura T; Minekawa Y; Suzuki N
Biken J; 1972 Sep; 15(3):173-7. PubMed ID: 4643692
[No Abstract] [Full Text] [Related]
34. Immunise Australia program: measles control campaign.
Commun Dis Intell; 1998 Aug; 22(8):156. PubMed ID: 9735549
[No Abstract] [Full Text] [Related]
35. [Vaccinations and serotherapy. Current problems].
Letonturier P
Minerva Med; 1973 Jun; 64(41):2135-46. PubMed ID: 4719824
[No Abstract] [Full Text] [Related]
36. Edmonston B and a further attenuated measles vaccine--a placebo controlled double blind comparison.
Miller G; Gale J; Villarejos V; James W; Arteaga CG; Casey H; Henderson DA
Am J Public Health Nations Health; 1967 Aug; 57(8):1333-40. PubMed ID: 4860064
[No Abstract] [Full Text] [Related]
37. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
Topciu V; Moldovan E; Csaky N; Băcilă E
Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
[No Abstract] [Full Text] [Related]
38. Wiping out measles: when to vaccinate?
Ratnam S; West R; Gadag V
CMAJ; 1997 Apr; 156(7):979, 982. PubMed ID: 9099164
[No Abstract] [Full Text] [Related]
39. Keeping immunizations up to date.
Reece RM
Am Fam Physician; 1974 Mar; 9(3):119-25. PubMed ID: 4855929
[No Abstract] [Full Text] [Related]
40. [Single or double dose of vaccine needed for the eradication of measles in Spain?].
Vitoria Miñana I; Morales Suárez-Varela M; Cotanda Gutiérrez P; Asensi Botet F
An Esp Pediatr; 1993 Feb; 38(2):130-4. PubMed ID: 8439098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
